On 28th January 2004 patient PT, aged 56, suffered an extensive and complicated
anterolateral myocardial infarction with low output syndrome and double ventricular …

The development of postoperative ventricular dysfunction immediately after heart
transplantation is a serious complication that leads to low-output syndrome and which …

Methods: Observational, prospective study of patients with AdHF awaiting heart transplant
(HTx), who received ambulatory ICL between January 2016 and November 2017. All …

[Effect of levosimendan treatment of myocardial stunning and low-output syndrome after
cardiac surgery]. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

We present a case of a 58-year-old male patient, with end-stage heart failure due to
ischemic heart disease for which a HeartMate II left ventricular assist device (LVAD) was …

Cardiogene shock (CS) is a syndrome caused by the incapacity of the heart to assure an
appropriate tissular perfusion for the methabolic needs, having as consequences an …

Purpose: Levosimendan is an effective new inotropic drug with unique pharmacological
advantages in patients with acute decompensated heart failure. The scope of this study was …

Zastosowanie lewosimendanu u chorych z ostrą niewydolnością serca z objawami małego
rzutu minutowego serca: opis serii przyp Page 1 www.kardiologiapolska.pl Kardiologia …

After heart transplantation primary graft failure is a major cause of early mortality. Treatment
options include inotropes and mechanical assist devices. Developing better methods would …